VBIV Annual Operating Expenses
$51.49 M
-$20.14 M-28.12%
31 December 2023
Summary:
As of January 19, 2025, VBIV annual total operating expenses is $51.49 million, with the most recent change of -$20.14 million (-28.12%) on December 31, 2023. During the last 3 years, it has risen by +$15.98 million (+44.99%).VBIV Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Quarterly Operating Expenses
$10.24 M
-$32.00 K-0.31%
31 March 2024
Summary:
As of January 19, 2025, VBIV quarterly total operating expenses is $10.24 million, with the most recent change of -$32.00 thousand (-0.31%) on March 31, 2024. Over the past year, it has dropped by -$3.97 million (-27.92%).VBIV Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VBIV Operating Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -28.1% | -27.9% |
3 y3 years | +45.0% | -44.4% |
5 y5 years | -12.7% | -44.4% |
VBIV Operating Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time | -28.1% | -51.1% |
VBI Vaccines Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Mar 2024 | - | $10.24 M(-0.3%) |
Dec 2023 | $51.49 M(-28.1%) | $10.27 M(-2.8%) |
Sept 2023 | - | $10.57 M(-25.6%) |
June 2023 | - | $14.21 M(-13.5%) |
Mar 2023 | - | $16.43 M(-10.7%) |
Dec 2022 | $71.63 M(+23.7%) | $18.40 M(-4.2%) |
Sept 2022 | - | $19.20 M(-7.4%) |
June 2022 | - | $20.73 M(+55.9%) |
Mar 2022 | - | $13.29 M(-24.9%) |
Dec 2021 | $57.89 M(+63.0%) | $17.69 M(+39.7%) |
Sept 2021 | - | $12.66 M(-9.2%) |
June 2021 | - | $13.95 M(+2.7%) |
Mar 2021 | - | $13.59 M(+13.6%) |
Dec 2020 | $35.51 M(-12.2%) | $11.96 M(+19.1%) |
Sept 2020 | - | $10.04 M(+60.2%) |
June 2020 | - | $6.27 M(-13.6%) |
Mar 2020 | - | $7.25 M(+288.8%) |
Dec 2019 | $40.42 M(-31.5%) | $1.86 M(-87.4%) |
Sept 2019 | - | $14.81 M(+40.3%) |
June 2019 | - | $10.55 M(-18.8%) |
Mar 2019 | - | $13.00 M(-34.0%) |
Dec 2018 | $58.98 M(+79.0%) | $19.69 M(+40.6%) |
Sept 2018 | - | $14.00 M(-6.0%) |
June 2018 | - | $14.90 M(+43.4%) |
Mar 2018 | - | $10.39 M(+4.4%) |
Dec 2017 | $32.95 M(+51.7%) | $9.95 M(+24.4%) |
Sept 2017 | - | $8.00 M(+9.6%) |
June 2017 | - | $7.30 M(-5.2%) |
Mar 2017 | - | $7.70 M(-0.2%) |
Dec 2016 | $21.73 M(+3.7%) | $7.71 M(+18.3%) |
Sept 2016 | - | $6.52 M(+23.9%) |
June 2016 | - | $5.26 M(+135.5%) |
Mar 2016 | - | $2.23 M(-86.2%) |
Dec 2015 | $20.96 M(+406.6%) | $16.14 M(+488.6%) |
Sept 2015 | - | $2.74 M(+189.3%) |
June 2015 | - | $948.00 K(+48.1%) |
Mar 2015 | - | $640.00 K(-54.2%) |
Mar 2015 | $4.14 M(-21.8%) | - |
Dec 2014 | - | $1.40 M(+13.5%) |
Sept 2014 | - | $1.23 M(+24.0%) |
June 2014 | - | $994.00 K(-36.3%) |
Mar 2014 | $5.29 M(-28.3%) | $1.56 M(-22.5%) |
Dec 2013 | - | $2.01 M(+99.1%) |
Sept 2013 | - | $1.01 M(+36.3%) |
June 2013 | - | $742.30 K(+6.4%) |
Mar 2013 | $7.38 M(-45.8%) | $697.80 K(-49.3%) |
Dec 2012 | - | $1.38 M(-54.2%) |
Sept 2012 | - | $3.01 M(+32.0%) |
June 2012 | - | $2.28 M(-34.8%) |
Mar 2012 | $13.61 M | $3.49 M(+22.9%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2011 | - | $2.84 M(-16.1%) |
Sept 2011 | - | $3.39 M(-16.0%) |
June 2011 | - | $4.04 M(-80.7%) |
Mar 2011 | $25.33 M(+3362.9%) | $20.94 M(+2731.4%) |
Dec 2010 | - | $739.70 K(-79.2%) |
Sept 2010 | - | $3.55 M(+168.7%) |
June 2010 | - | $1.32 M(+232.9%) |
Mar 2010 | $731.60 K(+183.3%) | $397.30 K(+150.7%) |
Dec 2009 | - | $158.50 K(+94.0%) |
Sept 2009 | - | $81.70 K(-1.9%) |
June 2009 | - | $83.30 K(+26.4%) |
Mar 2009 | $258.20 K(-55.2%) | $65.90 K(+2.5%) |
Dec 2008 | - | $64.30 K(-27.8%) |
Sept 2008 | - | $89.00 K(+47.1%) |
June 2008 | - | $60.50 K(-52.1%) |
Mar 2008 | $576.00 K(+60.5%) | $126.40 K(-23.1%) |
Dec 2007 | - | $164.40 K(-14.4%) |
Sept 2007 | - | $192.00 K(+144.3%) |
June 2007 | - | $78.60 K(-43.9%) |
Mar 2007 | $358.80 K(-13.5%) | $140.10 K(+124.5%) |
Dec 2006 | - | $62.40 K(-32.9%) |
Sept 2006 | - | $93.00 K(+32.5%) |
June 2006 | - | $70.20 K(-75.7%) |
Mar 2006 | $414.70 K(+206.3%) | $289.10 K(+709.8%) |
Dec 2005 | - | $35.70 K(-24.7%) |
Sept 2005 | - | $47.40 K(+13.4%) |
June 2005 | - | $41.80 K(-35.2%) |
Mar 2005 | $135.40 K(+2.4%) | $64.50 K(+279.4%) |
Dec 2004 | - | $17.00 K(-20.6%) |
Sept 2004 | - | $21.40 K(+0.5%) |
June 2004 | - | $21.30 K(-10.1%) |
Mar 2004 | $132.20 K(+61.2%) | $23.70 K(-48.6%) |
Dec 2003 | - | $46.10 K(+53.2%) |
Sept 2003 | - | $30.10 K(+1.7%) |
June 2003 | - | $29.60 K(-24.5%) |
Mar 2003 | $82.00 K(+15.5%) | $39.20 K(+326.1%) |
Dec 2002 | - | $9200.00(-51.8%) |
Sept 2002 | - | $19.10 K(+78.5%) |
June 2002 | - | $10.70 K(-64.9%) |
Mar 2002 | $71.00 K(+3.2%) | $30.50 K(+165.2%) |
Dec 2001 | - | $11.50 K(+5.5%) |
Sept 2001 | - | $10.90 K(-43.2%) |
June 2001 | - | $19.20 K(-14.3%) |
Dec 2000 | - | $22.40 K(-4.3%) |
Sept 2000 | - | $23.40 K(<-9900.0%) |
Mar 2000 | $68.80 K(-48.1%) | -$200.00(-100.3%) |
Sept 1999 | - | $68.10 K(+0.9%) |
Mar 1999 | $132.50 K(-6.0%) | $67.50 K(+3.1%) |
Sept 1998 | - | $65.50 K(-7.7%) |
Mar 1998 | $140.90 K(-2.8%) | $71.00 K |
Mar 1997 | $144.90 K | - |
FAQ
- What is VBI Vaccines annual total operating expenses?
- What is the all time high annual operating expenses for VBI Vaccines?
- What is VBI Vaccines annual operating expenses year-on-year change?
- What is VBI Vaccines quarterly total operating expenses?
- What is the all time high quarterly operating expenses for VBI Vaccines?
- What is VBI Vaccines quarterly operating expenses year-on-year change?
What is VBI Vaccines annual total operating expenses?
The current annual operating expenses of VBIV is $51.49 M
What is the all time high annual operating expenses for VBI Vaccines?
VBI Vaccines all-time high annual total operating expenses is $71.63 M
What is VBI Vaccines annual operating expenses year-on-year change?
Over the past year, VBIV annual total operating expenses has changed by -$20.14 M (-28.12%)
What is VBI Vaccines quarterly total operating expenses?
The current quarterly operating expenses of VBIV is $10.24 M
What is the all time high quarterly operating expenses for VBI Vaccines?
VBI Vaccines all-time high quarterly total operating expenses is $20.94 M
What is VBI Vaccines quarterly operating expenses year-on-year change?
Over the past year, VBIV quarterly total operating expenses has changed by -$3.97 M (-27.92%)